1,511 results on '"Gaulard, Philippe"'
Search Results
2. Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
3. Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma
4. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
5. MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models
6. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
7. Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma
8. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE
9. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution
10. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
11. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
12. Extranodal T- and NK-cell lymphomas
13. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
14. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation
15. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
16. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey
17. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target
18. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
19. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
20. Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1
21. Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
22. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
23. Hepatosplenic T-Cell Lymphoma
24. Peripheral T-Cell Lymphoma, Not Otherwise Specified
25. Impact des algorithmes du groupe français d’étude des lymphomes cutanés (GFELC) sur le diagnostic anatomopathologique des lymphoproliférations cutanées
26. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
27. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells
28. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
29. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment
30. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution
31. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
32. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
33. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
34. A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients
35. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations
36. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
37. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?
38. KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas
39. POSTER: TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas
40. Tumor necrosis factor receptor type 2 (TNFR2) may represent an alternative therapeutic target in Sézary syndrome and mycosis fungoides
41. TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas
42. Relecture centralisée du diagnostic histopathologique de lymphome. Résultats et perspectives d’une étude nationale à grande échelle
43. Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation
44. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
45. The Mutator Pathway Is a Feature of Immunodeficiency-Related Lymphomas
46. S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
47. P1224: PATIENT-DERIVED XENOGRAFT (PDX) IS A USEFUL TOOL FOR EVALUATING 5-AZACYTIDINE SENSITIVITY IN TFH LYMPHOMAS
48. S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY
49. How molecular advances may improve the diagnosis and management of PTCL patients
50. The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.